NEREA
ANCIZAR LIZARRAGA
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaInstituto de Investigación Sanitaria Biogipuzkoa-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2018
-
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: Pooled analysis in 4 basque country university hospitals
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 189-199
-
Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases
F1000Research, Vol. 6